ArticleIJID regions2026
Measles seroprevalence among health care professionals during a period of increased transmission: A pilot study in Southern Italy.
Article in IJID regions, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Measles continues to be a significant public health concern worldwide, with suboptimal vaccination coverage contributing to periodic outbreaks, even in Europe. Despite the availability of an effective vaccine, regional disparities and declining vaccination coverage, exacerbated by the COVID-19 pandemic, have increased the risk of measles transmission in Italy. Methods: This study aimed to assess measles seroprevalence among health care professionals (HCPs) and explore associated socio-demographic factors in a country with a high level of measles circulation. Results: Data were collected from 148 HCPs across two hospitals in Southern Italy. Serologic analyses were performed on 121 of the 148 enrolled HCPs, revealing an overall seroprevalence of 96%; however, there was a substantial proportion of non-immune young female HCPs. Furthermore, smoking was significantly associated with reduced immunoglobulin levels (adjusted odds ratio = 13.3; 95% confidence interval = 1.07-166.2; Conclusions: These findings underscore the importance of routine serological monitoring among HCPs to inform booster vaccination strategies to fill immunity gaps in high-risk groups and settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.